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Abstract The four highly conserved intracellular tyrosine res-
idues of the P2X1 ion channel were mutated into phenylalanine.
Simultaneous electrophysiological and calcium measurements in
transfected human embryonic kidney (HEK 293) cells indicated
that Y362F and Y370F mutants were non-functional, despite
their proper plasma membrane expression. The Y16F and
Y363F mutants retained 2.2% and 26% of the wild-type P2X1
activity, respectively. However, no tyrosine phosphorylation was
detected on Western blots of P2X1 immunoprecipitates derived
either from HEK 293 cell lysates or from human platelets, ex-
pressing P2X1 endogenously. Thus, Y16, Y362, Y363 and Y370
are required for the appropriate three-dimensional structure and
function of the intracellular P2X1 domains. 1 2002 Federation
of European Biochemical Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
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1. Introduction
P2X receptors are ATP-gated cation channels constituting a
subfamily of purinergic (P2) receptors comprising seven dis-
tinct members (P2X1^P2X7) [1]. They form homo- or hetero-
oligomeric ion channels in numerous excitable and non-excit-
able cell types and regulate a broad range of physiological
processes [2]. The P2X1 receptor mediates rapidly desensitiz-
ing non-selective cation in£ux [3] ; generation of P2X1-null
mice has demonstrated a crucial role for the receptor in nor-
mal male fertility [4], but contributions to human bladder
function [5], to vascular smooth muscle tone regulation [6]
and to platelet activation [7,8] have also been suggested.
P2X subunits contain intracellular N- and C-termini and
two hydrophobic membrane-spanning segments separated by
a huge, highly glycosylated extracellular loop [9]. Although
the channel pore, allowing entry of Naþ, Kþ and also Ca2þ
ions, is believed to be in the second transmembrane domain,
other domains, including the ¢rst transmembrane domain and
the intracellular N- and C-terminal regions, also strongly con-
tribute to the complex multifactorial allosteric process of
channel pore opening and closing [10]. Indeed, truncations,
deletions and mutations in these regions greatly a¡ect the
kinetics, permeation and desensitization of P2X channels [11].
Phosphorylation of intracellular serine, threonine and tyro-
sine residues is an important mechanism to modulate short-
and long-term activity of ion channels and cell surface recep-
tors [12]. In the slowly desensitizing P2X7 channel, phosphor-
ylation of a single tyrosine residue at position 343 is required
to maintain the run-down of the current as well as to sustain
the interaction of P2X7 with several, mainly cytoskeletal pro-
teins [13]. In contrast, P2X2 was reported not to be phosphor-
ylated on tyrosines [13] although substitution of the conserved
Y16 with cysteine leads to complete loss of ion channel func-
tion [14].
In this study, using site-directed mutagenesis, we found that
substitution of any of the four highly conserved intracellular
tyrosine residues with phenylalanine greatly reduces or abol-
ishes the P2X1 channel function. Phosphorylated tyrosines
were not detected in P2X1 immunoprecipitates from trans-
fected human embryonic kidney (HEK 293) cells or human
platelets. We conclude that intact intracellular tyrosine resi-
dues are required to generate the inward cation current upon
P2X1 stimulation and propose that they assure the integrity of
the three-dimensional organization of the P2X1 subunits.
2. Materials and methods
2.1. Cell culture and transfections
HEK 293 cells [15] were transfected using the FuGENE 6 trans-
fection reagent (Roche Diagnostics) according to the instructions of
the manufacturer.
2.2. Expression vectors and mutagenesis of the human P2X1 receptor
Site-directed mutagenesis was performed by the overlap primer ex-
tension method [16]. The previously described pcDNA3-P2X1 expres-
sion vector [15] was taken as the template for PCR (Taq polymerase,
Gibco). The following overlapping primers were used: Y16F: 5P-CA-
TGCGGGGGGTGTCAAACTCG-3P, 5P-GCCTTCCTCTTCGAGT-
TTGACA-3P ; Y362F: 5P-CTTCTTCTGCTTGTAGAAGTGC-3P, 5P-
CTGCCTAAGAGGCACTTCTACA-3P ; Y363F: 5P-GAACTTCTT-
CTGCTTGAAGTAG-3P, 5P-GCCTAAGAGGCACTACTTCAAG-
C-3P ; Y370F: 5P-CCCATGTCCTCAGCGAATTTG-3P, 5P-CAGAA-
GAAGTTCAAATTCGCT-3P, together with primers speci¢c for the
pcDNA3 SP6- and T7-promoter sequences: SP6: 5P-GCATTTAGG-
TGACACTATAGAATAG-3P, T7: 5P-TAATACGACTCACTATA-
GGG-3P. Y16F, Y362F, Y363F and Y370F pcDNA3 and pcI-neo-
IRES-GFP [17] expression vectors were produced. Oligonucleotide
primers were designed to introduce the FLAG epitope (DYKDDD-
DK) into the carboxyl-termini of the P2X1 wild type, immediately
upstream of the stop codon: 5P-CCAGACCTCGAGCGGCCTCAT-
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CAGG-3P, 5P-CCCTCTAGATTACTTGTCATCGTCATCCTTGTA-
GTCGGATGTCCTCATGTTCTCCTG-3P. All constructs were veri-
¢ed by sequencing (AutoRead Sequencing kit, Pharmacia Biotech).
2.3. Immunostaining and confocal microscopy
Immuno£uorescent staining and confocal microscopy of HEK 293
cells grown on polylysine-coated culture slides were performed as
described, using 25 Wg/ml polyclonal rabbit anti-P2X1 antibodies [15].
2.4. Electrophysiological recordings
P2X1 function was analyzed 36^72 h after transfection with the
bicistronic pcI-neo-IRES-GFP expression vector, using the whole-
cell patch clamp method as previously described [15]. Brie£y, the
standard external bath solution contained 150 mM NaCl, 6 mM
CsCl, 1 mM MgCl2, 1.5 mM CaCl2, 10 mM HEPES, 10 mM glucose,
50 mM mannitol (pH 7.4). The patch pipet solution contained 40 mM
CsCl, 100 mM aspartic acid, 1 mM MgCl2, 10 mM HEPES, 5 mM
EGTA, 1.928 mM CaCl2 at pH 7.2 to adjust the free [Ca2þ]i to 100
nM which suppresses activation of the endogenous Ca2þ-activated
Cl3 channels in HEK 293 cells (Ca-bu¡er program; G. Droogmans,
ftp://ftp.cc.kuleuven.ac.be/pub/droogmans/cabuf.zip). ATP (100 WM,
Sigma) was applied for 10 s, at 380 mV holding potential. Data
were sampled at 5 ms, ¢ltered at 3 kHz; statistical comparison was
made using the non-paired Student t-test.
2.5. Intracellular calcium concentration measurement
Cells were loaded with fura-2 (Kþ salt, 100 WM) included in the
internal solution (40 mM CsCl, 100 mM aspartic acid, 1 mM MgCl2,
10 mM HEPES and 0.1 mM EGTA) and applied through the pipet.
Excitation wavelengths were alternatively 360 and 390 nm; £uores-
cence was measured at 510 nm. Apparent free Ca2þ concentration was
calculated after subtraction of auto£uorescence, from the £uorescence
ratio R : [Ca2þ]i =Keff (R3R0)/(R13R) (Keff , e¡ective binding con-
stant; R0, £uorescence ratio at zero calcium concentration; R1, £uo-
rescence ratio at high Ca2þ concentration) [18]. For simultaneous
measurements of membrane current and [Ca2þ]i, currents were moni-
tored in voltage clamp mode with an EPC-9 ampli¢er (HEKA Elek-
tronik, Lambrecht, Germany, sampling rate 1 ms, 8-pole Bessel ¢lter
2.9 kHz).
2.6. Immunoprecipitation and Western blotting of P2X1 proteins
HEK 293 cells expressing the FLAG-tagged P2X1 were lysed in ice-
cold 1% Triton X-100 bu¡er (50 mM Tris^HCl, pH 7.4, 150 mM
NaCl, 1 mM EDTA, 1% Triton X-100) containing 1/25 diluted pro-
tease inhibitor cocktail tablets (Boehringer, Mannheim, Germany), 25
Fig. 1. Sequence alignment of human P2X receptors. Conserved tyrosine residues are boxed with solid lines and partially conserved residues
with dashed lines. P2X1 transmembrane domains (TM1 and TM2) are overlined with a bar. GI accession numbers are: 1709519, 12643353,
3024336, 2499422, 12643425, 3914240, 3915804 for the human P2X1^P2X7, respectively.
C
Fig. 2. Normal membrane localization and expression level of mu-
tant P2X1 channels. A: Confocal microscopy, following immuno-
staining of the wt and the four mutant P2X1 channels in stably
transfected HEK 293 cells. Non-transfected (NT) cells are shown as
negative controls. B: Western blots of wt and mutant P2X1-express-
ing HEK 293 cell extracts (same batch of cells used for electrophysi-
ological measurements).
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mM sodium £uoride and 1 mM sodium vanadate. When indicated,
cells were pretreated with a selective, non-hydrolyzable agonist, K,L-
methyleneATP (K,L-meATP, 100 WM, Sigma) for 1 min, with 1 U/ml
apyrase (Grade I, Sigma) for 45 min or with 100 WM NaVO3 for 30
min prior to extraction. Immunoprecipitation was performed by add-
ing equilibrated anti-FLAG M2 a⁄nity gel (Sigma) according to the
protocol provided by the manufacturer. Proteins were separated on
12.5% SDS^polyacrylamide gel and were transferred to nitrocellulose
membranes. Phosphorylated tyrosines were detected with a murine
monoclonal horseradish peroxidase (HRP)-conjugated anti-phospho-
tyrosine antibody (HRP-4G10 clone, Campro Scienti¢c). After strip-
ping, total P2X1 proteins were revealed by the home-made biotinyl-
ated rabbit anti-P2X1 antibody [19] using the ABComplex (Dako).
The same antibody was used for direct Western blotting detection
of P2X1 mutant proteins. Protein bands were visualized with an
ECL kit (Amersham Pharmacia).
2.7. Preparation of washed human platelets and shape change analysis
Fresh blood obtained from healthy donors was anti-coagulated
with acid^citrate^dextrose pH 6.2 (ACD) and centrifuged at 150Ug
for 15 min in the presence of 1 U/ml apyrase. Platelet-rich plasma was
diluted three-fold with ACD before centrifugation at 800Ug for 10
min. Platelets were resuspended at 2.5U105 platelets/Wl in Tyrode’s
bu¡er (137 mM NaCl, 12 mM NaHCO3, 2 mM KCl, 0.34 mM
Na2HPO4, 5.5 mM glucose, 1 mM MgCl2 and 5 mM HEPES, pH
7.3) containing 2 U/ml apyrase. The apyrase treatment, by degrading
nucleotides released during platelet preparation, is required to main-
tain P2X1 functionality [7]. P2X1-mediated platelet shape change was
recorded as a decrease in light transmission on an ELVI 840 aggreg-
ometer.
2.8. Immunoprecipitation of the P2X1 receptor from human platelets
900 Wl aliquots of washed human platelets were lysed with 10U
concentrated ice-cold bu¡er containing protease and phosphatase in-
hibitors (see Section 2.6). When indicated, platelets were preincubated
with 100 WM NaVO3, stimulated with 2.5 WM K,L-meATP or with
1 Wg/ml collagen (collagen reagent horm, Nycomed). Immunoprecip-
itation was performed using 25 Wg/ml of a home-made rabbit anti-
P2X1-FLAG antibody and 50 Wl of protein G beads (Santa Cruz).
This antibody was raised against the native P2X1-FLAG protein ex-
pressed in HEK 293 cells. After overnight incubation at 4‡C, proteins
were eluted with SDS bu¡er and were separated by 12.5% SDS^
PAGE. Detection of the P2X1 protein and the phosphotyrosine resi-
dues was performed as above (see Section 2.6)
3. Results and discussion
3.1. Normal membrane localization and expression level of the
mutated P2X1 channels
Sequence alignment of the rat, mouse and human P2X1
indicates that the intracellular tyrosine residues in the N-
and C-termini are conserved among di¡erent species. More-
over, intracellular tyrosines are completely (Y16, Y363) or
partially (Y362, Y370) conserved within the human P2X ion
channel family (Fig. 1). We mutated these residues into phe-
nylalanine, generating four mutants (Y16F, Y362F, Y363F,
Y370F). Immunostaining of wild-type (wt) and mutant P2X1-
transfected HEK 293 cells revealed similar expression, overall
subcellular distribution and proper plasma membrane local-
ization (Fig. 2A). Western blot analyses also indicated identi-
cal total P2X1 protein levels (Fig. 2B).
3.2. Mutant P2X1 subunits form non-functional or
incapacitated channels
The P2X1 channel mediates a rapidly desensitizing fast in-
ward cation current, coinciding with an explicit intracellular
calcium increase [2]. Saturating concentrations of ATP (100
Fig. 3. P2X1 channel activity in transfected HEK 293 cells. A: Representative examples of ATP-induced inward currents and parallel intracellu-
lar calcium measurements in wt and Y16F, Y362F, Y363F, Y370F P2X1-expressing cells. Agonist application is depicted by bars. ^ = level of
zero current or zero calcium concentration. Note the di¡erent current scale for the inactive mutants. B: Summary of the ATP-induced mean
peak current recorded during the separate electrophysiological measurements. C: Main peak intracellular calcium increase in HEK 293 cells
transfected with mutant cDNAs. Values are expressed as a percentage of the wt channel activity. (*P6 0.005, **P6 0.001.)
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WM) induced a robust inward current and an accompanying
intracellular calcium increase in all wt transfected cells (mean
peak current U S.E.M.= 0.7191U 0.193 nA/pF, n=10; mean
peak calcium increase U S.E.M.= 0.3852U 0.0538 WM, n=8)
(Fig. 3A). The Y362F and Y370F mutants were non-func-
tional (no current, n=4 and 5, respectively) and unable to
trigger intracellular calcium in£ux (mean peak increase U
S.E.M.= 0.0206U 0.006 and 0.0146U 0.005 WM, respectively,
n=5 for both mutants, P6 0.001). The Y16F mutant retained
2.2% of wt channel activity (mean peak current U
S.E.M.= 0.023U 0.015 nA/pF, n=4, P6 0.001), detectable
only by high-sensitivity patch clamp measurements. Finally,
the Y363F mutant was 26% active (mean peak current U
S.E.M.= 0.105U 0.0376 nA/pF, n=7, P6 0.005 and mean
peak calcium increase US.E.M.= 0.1155U 0.041 WM, n=6,
P6 0.001) (Fig. 3A). The Y16F and Y362F mutants had a
rapidly desensitizing phenotype similar to that of the wt P2X1.
Non-transfected cells did not generate ion currents in response
to ATP, but 15% of the cells produced a slow, delayed cal-
cium increase in the absence of ion in£ux after ATP applica-
tion. This can be explained by the fact that some HEK 293
cell lines express endogenous P2 receptors belonging to the
metabotropic P2Y family [19]. Therefore, to calculate ATP-
induced calcium increases, we used only those cells where the
increase of Ca2þ coincided with the fast inward current.
These results indicate that substitution of tyrosines at posi-
tions 362 and 370 abolishes channel activity, while substitu-
tion of Y16 and Y363 drastically reduces it, showing the re-
quirement of these residues for P2X1 channel function (Fig.
3B,C). Generation of ion movement through the channel pore
is a complex, delicate process, requiring several consecutive
critical events. Since the ATP-binding site of P2X channels
is located extracellularly [14], the most plausible explanation
for the observed loss of activity would rely either on the
impaired ability of the channel to open when ATP is bound,
re£ecting a decreased gating ability, or on reduced permea-
tion, leading to loss of the current through the open channel.
3.3. Lack of tyrosine phosphorylation of the heterologously
expressed and endogenous P2X1 proteins
Phosphorylation of intracellular tyrosines provides control
of receptor function, signaling events and assembly of multi-
protein complexes. To assess whether the loss of ion channel
activity is due to de¢cient tyrosine phosphorylation, we have
searched for phosphorylated tyrosine residues in the wt P2X1.
Since the C-terminal FLAG sequence does not a¡ect the
properties of the P2X1 channel [20], we transfected HEK
293 cells with a FLAG-tagged P2X1 pcDNA3 expression vec-
tor to facilitate the immunoprecipitation procedure. Cells
were treated with apyrase prior to extraction, to prevent re-
ceptor desensitization via breakdown of the spontaneously
released nucleotides in cell culture media [21]. Cells were
Fig. 4. Lack of tyrosine phosphorylation of the P2X1 protein. A: Western blot detection of wt P2X1-FLAG proteins immunoprecipitated from
transfected HEK 293 cell extracts using an anti-phosphotyrosine 4G10-HRP-conjugated antibody (upper panel) or a polyclonal anti-P2X1 anti-
body (lower panel). Lanes are: immunoprecipitation without cell lysate (1), non-transfected cells (2), wt transfected cells (3), wt cells treated
with apyrase (4) and with NaVO3 (5), or stimulated with K,L-meATP (6). B: Western blot detection of phosphorylated (upper panel) and total
(lower panel) P2X1 proteins immunoprecipitated from human platelets. Lanes are: immunoprecipitation without platelet lysate (1), resting (2),
resting, NaVO3-treated platelets (3), platelets stimulated with K,L-meATP for 5 (4) and 30 (5) s. C: Shape change induced by 2.5 WM K,L-
meATP in human washed platelets. Lower arrows indicate the time of protein extraction, upper arrow represents the agonist application. Scales
are light transmission and time, respectively. D: Tyrosine phosphorylation of platelet cytoskeletal proteins before and after stimulation with
collagen (1 Wg/ml, 5 min) using the same anti-phosphotyrosine antibody as in (A) and (B). E: Schematic representation of the P2X1 subunit
structure and intracellular tyrosines. The opposite orientation of Y363 to Y362 is indicated by arrow symbols.
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also preincubated with the phosphatase inhibitor NaVO3 or
with the non-hydrolyzable P2X1 agonist K,L-meATP. Repeti-
tive Western blotting experiments failed to reveal phosphory-
lated tyrosines in the wt P2X1 in any of these conditions (Fig.
4A).
Human platelets exclusively express the P2X1 ion channel
responsible for rapid, reversible calcium in£ux leading to
platelet shape change [7]. Therefore, we used washed human
platelets as native, P2X1-expressing cells for immunoprecipi-
tation; platelet shape change was analyzed in parallel to docu-
ment preservation of P2X1 functionality. We found no evi-
dence of tyrosine phosphorylation in resting, in NaVO3-
treated or in K,L-meATP-stimulated platelets (Fig. 4B), even
though the receptor was functional at the time of protein
extraction (Fig. 4C). On the contrary, the collagen-induced
tyrosine phosphorylation of numerous platelet cytoskeletal
proteins [22] was clearly detected using the HRP-conjugated
anti-phosphotyrosine antibody, as expected (Fig. 4D).
Our data indicate that all four P2X1 tyrosine residues are
required for an appropriate cation in£ux through the channel.
Since no tyrosine phosphorylation can be detected in hetero-
logously or endogenously expressed P2X1 protein and the
mutagenesis of either of the two adjacent residues (Y362
and Y363) leads to loss of function, the role of intracellular
tyrosines in P2X1 appears to be structural.
Since P2X1 channels are thought to be composed of at least
three homo-oligomers [1], 12 intracellular tyrosine residues are
expected for each channel. Although the three-dimensional
structure of the P2X-type ion channels is unknown, the N-
and C-terminal tails are thought to be close to each other,
sitting underneath the channel in a closed state (Fig. 4E) [2].
We speculate that the intracellular tyrosine residues contribute
to a well-de¢ned structure, localized just beneath the channel
pore region. Tyrosine hydroxyl groups, by creating intramo-
lecular hydrogen bounds, are important for protein folding
[23] and contribute to protein stability [24]. It would therefore
be interesting to determine whether similar structure^function
relations exist in other P2X members. The most likely candi-
date for such a study would be the P2X4 receptor, containing
tyrosine-rich, short intracellular regions, highly homologous
to those of P2X1.
In conclusion, we report that intact intracellular tyrosine
residues are essential to maintain the functionality of the rap-
idly desensitizing ATP-activated P2X1 ion channel.
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